Access and Benefit Sharing Under the Nagoya Protocol-Quo Vadis? Six Latin American Case Studies Assessing Opportunities and Risk
BackgroundGlobal challenges related to access and benefit sharing (ABS) of biological resources have become a key concern in the area of research on herbal medicines, ethnopharmacology, drug discovery, and the development of other high value products for which Intellectual Property protection can be...
Saved in:
Main Authors: | Michael Heinrich (Author), Francesca Scotti (Author), Adolfo Andrade-Cetto (Author), Monica Berger-Gonzalez (Author), Javier Echeverría (Author), Fabio Friso (Author), Felipe Garcia-Cardona (Author), Alan Hesketh (Author), Martin Hitziger (Author), Caroline Maake (Author), Matteo Politi (Author), Carmenza Spadafora (Author), Rita Spadafora (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Quo vadis ?
by: Sielie Eales
Published: (2000) -
CLINICAL AND MACROSCOPICAL ANATOMY - QUO VADIS?. Anatomía Clínica y Macroscópica - Quo vadis?
by: Georg C Feigl
Published: (2019) -
Reseña: ¿Quo vadis, Universidad?
by: Antonio Bolívar
Published: (2016) -
ChatGPT- Quo vadis?
by: Feroze Kaliyadan, et al.
Published: (2023) -
Tuberculosis research: Quo vadis
by: Nerges Mistry
Published: (2024)